However, the levels of IFN-λ2 in severe cases of coronavirus disease 2019 (COVID-19) have been reported to be lower than in the mild disease group (26), suggesting an important role of IFN-λ in the outcome of the disease and that the virus possesses mechanisms to inhibit IFN-λ expression. This evidence concerns the gene IFNL2 and COVID-19.